| Determination of In Vivo Effective Diffusion Rates of Therapeutics from Controlled Release Systems | Dr. Siddharth Jhunjhunwala, Indian Institute Of Science, Bangalore, Karnataka | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India | Dr. J N Verma, Lifecare Innovations Private Limited, Gurgaon, Haryana (122018) | 2024 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Stereoselective Synthesis of Structurally Diverse Sp3-rich Polycyclic Scaffolds: Generation of High valued New Molecular Entities (NMEs) for GPCR Modulators | Dr. Ravindra Kumar, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Controlled Drug Delivery in Oral Osmotic Tablets: Experiments and Modelling | Prof. Mahesh S Tirumkudulu, Indian Institute Of Technology (IIT) Bombay, Maharashtra | 2023 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Molecular explorations of the Leishmania donovani Homoserine Dehydrogenase and evaluating the impact of its perturbations using CRISPR-Cas9 system’’ | Dr. Sushma Singh, Associate Professor, National Institute of Pharmaceutical Education and Research (NIPER), | 2023 | | Pharmaceutical Sciences |
| Unraveling the neuroprotective mechanism of Vitexin and Thymol synergistic combination against tau hyperphosphorylation and neuroinflammation: a therapeutic approach for the treatment of Alzheimer’s disease | Dr. Pandima Devi Kasi, Alagappa University, Tamil Nadu | 2023 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| Bioisosteric Approach for the Synthesis of Fumitremorgin C, Tariquidar and Elacridar Analogues for Reversing Multidrug Resistance in Cancer | Dr. Neetu Kumari, Mohan Lal Sukhadia University, Rajasthan | 2023 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Understanding the impact of drug-herbal dietary supplements pharmacokinetic interactions: Integrated transcriptomics analysis to study the key metabolism, pathways, and safety evaluation | Dr. Satheeshkumar Nanjappan, Associate Professor, National Institute of Pharmaceutical Education and Research, Kolkata | 2023 | | Pharmaceutical Sciences |
| Design and Synthesis of Rhabdopeptide/Xenortide-like peptides, and structurally diverse, hybrid sulfonamide and amide derivatives of amino acids, and their medicinal application | Dr. Surendra Puri, Hemwati Nandan Bahuguna Garhwal University, Uttarakhand | 2023 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| Synthesis and evaluation of novel dual GSK-3β/HDAC inhibitor as an anti-Alzheimer agent | Dr. Abha Sharma, Associate Professor, National Institute of Pharmaceutical Education and Research, Raebareli | 2023 | | Pharmaceutical Sciences |